Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials.
Saved in:
| Title: | Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials. |
|---|---|
| Authors: | Abuhelwa AY; College of Pharmacy, University of Sharjah, Sharjah, UAE. Ahmad.Abuhelwa@sharjah.ac.ae.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, UAE. Ahmad.Abuhelwa@sharjah.ac.ae., Almansour SA; College of Pharmacy, University of Sharjah, Sharjah, UAE., Al-Shamsi HO; Department of Oncology, Burjeel Cancer Institute, Burjeel Medical City, P.O. Box 92510, Abu Dhabi, UAE.; Emirates Oncology Society, P.O.Box: 6600, Dubai, UAE.; College of Medicine, Ras Al Khaimah Medical and Health Sciences, Ras Al Khaimah, UAE.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Abuhelwa Z; Department of Hematology and Medical Oncology, University of South Florida/ H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA., Alqudah MAY; College of Pharmacy, University of Sharjah, Sharjah, UAE.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, UAE.; Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan., Bustanji Y; College of Medicine, University of Sharjah, Sharjah, UAE.; Faculty of Pharmacy, the University of Jordan, Amman, Jordan., Semreen MH; College of Pharmacy, University of Sharjah, Sharjah, UAE.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, UAE., Alzoubi KH; College of Pharmacy, QU Health, Qatar University, Doha, Qatar.; Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan., Modi ND; Clinical and Health Sciences, University of South Australia, Adelaide, Australia., McKinnon RA; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia., Sorich MJ; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia., Hopkins AM; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia. |
| Source: | Scientific reports [Sci Rep] 2026 Feb 07; Vol. 16 (1). Date of Electronic Publication: 2026 Feb 07. |
| Publication Type: | Journal Article; Clinical Trial, Phase III |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41651961 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Abuhelwa+AY%22">Abuhelwa AY</searchLink>; College of Pharmacy, University of Sharjah, Sharjah, UAE. Ahmad.Abuhelwa@sharjah.ac.ae.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, UAE. Ahmad.Abuhelwa@sharjah.ac.ae.<br /><searchLink fieldCode="AU" term="%22Almansour+SA%22">Almansour SA</searchLink>; College of Pharmacy, University of Sharjah, Sharjah, UAE.<br /><searchLink fieldCode="AU" term="%22Al-Shamsi+HO%22">Al-Shamsi HO</searchLink>; Department of Oncology, Burjeel Cancer Institute, Burjeel Medical City, P.O. Box 92510, Abu Dhabi, UAE.; Emirates Oncology Society, P.O.Box: 6600, Dubai, UAE.; College of Medicine, Ras Al Khaimah Medical and Health Sciences, Ras Al Khaimah, UAE.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Abuhelwa+Z%22">Abuhelwa Z</searchLink>; Department of Hematology and Medical Oncology, University of South Florida/ H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.<br /><searchLink fieldCode="AU" term="%22Alqudah+MAY%22">Alqudah MAY</searchLink>; College of Pharmacy, University of Sharjah, Sharjah, UAE.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, UAE.; Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.<br /><searchLink fieldCode="AU" term="%22Bustanji+Y%22">Bustanji Y</searchLink>; College of Medicine, University of Sharjah, Sharjah, UAE.; Faculty of Pharmacy, the University of Jordan, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Semreen+MH%22">Semreen MH</searchLink>; College of Pharmacy, University of Sharjah, Sharjah, UAE.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, UAE.<br /><searchLink fieldCode="AU" term="%22Alzoubi+KH%22">Alzoubi KH</searchLink>; College of Pharmacy, QU Health, Qatar University, Doha, Qatar.; Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.<br /><searchLink fieldCode="AU" term="%22Modi+ND%22">Modi ND</searchLink>; Clinical and Health Sciences, University of South Australia, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22McKinnon+RA%22">McKinnon RA</searchLink>; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Sorich+MJ%22">Sorich MJ</searchLink>; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Hopkins+AM%22">Hopkins AM</searchLink>; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2026 Feb 07; Vol. 16 (1). <i>Date of Electronic Publication: </i>2026 Feb 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase III – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41651961 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-026-37464-4 Languages: – Code: eng Text: English Titles: – TitleFull: Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Abuhelwa AY – PersonEntity: Name: NameFull: Almansour SA – PersonEntity: Name: NameFull: Al-Shamsi HO – PersonEntity: Name: NameFull: Abuhelwa Z – PersonEntity: Name: NameFull: Alqudah MAY – PersonEntity: Name: NameFull: Bustanji Y – PersonEntity: Name: NameFull: Semreen MH – PersonEntity: Name: NameFull: Alzoubi KH – PersonEntity: Name: NameFull: Modi ND – PersonEntity: Name: NameFull: McKinnon RA – PersonEntity: Name: NameFull: Sorich MJ – PersonEntity: Name: NameFull: Hopkins AM IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 02 Text: 2026 Feb 07 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2045-2322 Numbering: – Type: volume Value: 16 – Type: issue Value: 1 Titles: – TitleFull: Scientific reports Type: main |
| ResultId | 1 |